Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Bolognesi

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
American Journal of Hematology|May 1, 1988
Transmission of human immunodeficiency virus to sexual partners of hemophiliacsM L Smiley, G C White, P Becherer, et al.
Journal of Virology|June 1, 1987
Characteristics of the specific cell-mediated immune response in human immunodeficiency virus infectionB Wahren, L Morfeldt-Månsson, G Biberfeld, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 1, 1985
3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitroH Mitsuya, K J Weinhold, P A Furman, et al.
Nature Medicine|November 11, 1998
Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entryJ M Kilby, S Hopkins, T M Venetta, et al.
AIDS Research and Human Retroviruses|June 30, 2000
A phase II study of two HIV type 1 envelope vaccines, comparing their immunogenicity in populations at risk for acquiring HIV type 1 infection. AIDS Vaccine Evaluation GroupM J McElrath, L Corey, D Montefiori, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
American Journal of Hematology|May 1, 1988
Transmission of human immunodeficiency virus to sexual partners of hemophiliacsM L Smiley, G C White, P Becherer, et al.
Journal of Virology|June 1, 1987
Characteristics of the specific cell-mediated immune response in human immunodeficiency virus infectionB Wahren, L Morfeldt-Månsson, G Biberfeld, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 1, 1985
3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitroH Mitsuya, K J Weinhold, P A Furman, et al.
Nature Medicine|November 11, 1998
Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entryJ M Kilby, S Hopkins, T M Venetta, et al.
AIDS Research and Human Retroviruses|June 30, 2000
A phase II study of two HIV type 1 envelope vaccines, comparing their immunogenicity in populations at risk for acquiring HIV type 1 infection. AIDS Vaccine Evaluation GroupM J McElrath, L Corey, D Montefiori, et al.
Pageof 2